Two-micrometer thulium laser resection of the prostate-tangerine technique for patients with acute urinary retention.
Identifieur interne : 000231 ( PubMed/Corpus ); précédent : 000230; suivant : 000232Two-micrometer thulium laser resection of the prostate-tangerine technique for patients with acute urinary retention.
Auteurs : Jian Zhuo ; Hai-Bin Wei ; Fu-Jun Zhao ; Feng Sun ; Bang-Min Han ; Xiao-Wen Sun ; Shu-Jie XiaSource :
- Lasers in medical science [ 1435-604X ] ; 2014.
English descriptors
- KwdEn :
- MESH :
- complications : Prostatic Hyperplasia.
- etiology : Urinary Retention.
- surgery : Urinary Retention.
- Acute Disease, Aged, Aged, 80 and over, Humans, Laser Therapy, Lasers, Solid-State, Length of Stay, Male, Middle Aged, Postoperative Period, Prospective Studies, Quality of Life, Treatment Outcome.
Abstract
Two-micrometer thulium laser resection of the prostate-tangerine technique (TmLRP-TT) has been introduced as a minimally invasive treatment for benign prostatic hyperplasia (BPH). Acute urinary retention (AUR) is a common and serious complication of BPH. The study was undertaken to assess the clinical efficacy and safety of TmLRP-TT in the treatment of patients with AUR secondary to BPH. A prospective evaluation of 52 patients undergoing TmLRP-TT from December 2011 to November 2012 was carried out. Preoperative status, surgical details, and perioperative complications were recorded. The follow-up outcome was evaluated with subjective and objective tests at 1 and 6 months. Mean age was 70.3 ± 7.8 years old. Mean prostate volume was 69.6 ± 31.6 ml, and mean residual volume with retention was 274.5 ± 150.7 ml. Mean operative time was 64.1 ± 30.4 min. Mean catheterization duration was 5.4 ± 1.1 days. The mean International Prostate Symptom Score, quality of life score, and postvoid residual urine volume decreased significantly at 6-month follow-up (21.6 ± 6.8 vs. 6.8 ± 3.2, 4.4 ± 1.2 vs. 0.9 ± 0.8, 274.5 ± 150.7 vs. 40.6 ± 22.5 ml). The mean maximum urinary flow rate was 18.7 ± 6.9 ml/s postoperative. Two (3.8 %) of the patients required blood transfusion in operation. Five (9.6 %) of the patients had transient hematuria postoperative, and two (3.8 %) of them received 3 days recatheterization due to clot retention. The early clinical results suggest that the TmLRP-TT is a promising safe, effective, and minimally invasive treatment for patients with AUR secondary to BPH. The incidence of complications was low.
DOI: 10.1007/s10103-013-1474-3
PubMed: 24189927
Links to Exploration step
pubmed:24189927Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Two-micrometer thulium laser resection of the prostate-tangerine technique for patients with acute urinary retention.</title><author><name sortKey="Zhuo, Jian" sort="Zhuo, Jian" uniqKey="Zhuo J" first="Jian" last="Zhuo">Jian Zhuo</name><affiliation><nlm:affiliation>Department of Urology, Shanghai First People's Hospital, School of Medicine, Shanghai Jiao Tong University, No.100, Haining Road, Shanghai, 200080, People's Republic of China.</nlm:affiliation></affiliation></author><author><name sortKey="Wei, Hai Bin" sort="Wei, Hai Bin" uniqKey="Wei H" first="Hai-Bin" last="Wei">Hai-Bin Wei</name></author><author><name sortKey="Zhao, Fu Jun" sort="Zhao, Fu Jun" uniqKey="Zhao F" first="Fu-Jun" last="Zhao">Fu-Jun Zhao</name></author><author><name sortKey="Sun, Feng" sort="Sun, Feng" uniqKey="Sun F" first="Feng" last="Sun">Feng Sun</name></author><author><name sortKey="Han, Bang Min" sort="Han, Bang Min" uniqKey="Han B" first="Bang-Min" last="Han">Bang-Min Han</name></author><author><name sortKey="Sun, Xiao Wen" sort="Sun, Xiao Wen" uniqKey="Sun X" first="Xiao-Wen" last="Sun">Xiao-Wen Sun</name></author><author><name sortKey="Xia, Shu Jie" sort="Xia, Shu Jie" uniqKey="Xia S" first="Shu-Jie" last="Xia">Shu-Jie Xia</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2014">2014</date><idno type="doi">10.1007/s10103-013-1474-3</idno><idno type="RBID">pubmed:24189927</idno><idno type="pmid">24189927</idno><idno type="wicri:Area/PubMed/Corpus">000231</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000231</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Two-micrometer thulium laser resection of the prostate-tangerine technique for patients with acute urinary retention.</title><author><name sortKey="Zhuo, Jian" sort="Zhuo, Jian" uniqKey="Zhuo J" first="Jian" last="Zhuo">Jian Zhuo</name><affiliation><nlm:affiliation>Department of Urology, Shanghai First People's Hospital, School of Medicine, Shanghai Jiao Tong University, No.100, Haining Road, Shanghai, 200080, People's Republic of China.</nlm:affiliation></affiliation></author><author><name sortKey="Wei, Hai Bin" sort="Wei, Hai Bin" uniqKey="Wei H" first="Hai-Bin" last="Wei">Hai-Bin Wei</name></author><author><name sortKey="Zhao, Fu Jun" sort="Zhao, Fu Jun" uniqKey="Zhao F" first="Fu-Jun" last="Zhao">Fu-Jun Zhao</name></author><author><name sortKey="Sun, Feng" sort="Sun, Feng" uniqKey="Sun F" first="Feng" last="Sun">Feng Sun</name></author><author><name sortKey="Han, Bang Min" sort="Han, Bang Min" uniqKey="Han B" first="Bang-Min" last="Han">Bang-Min Han</name></author><author><name sortKey="Sun, Xiao Wen" sort="Sun, Xiao Wen" uniqKey="Sun X" first="Xiao-Wen" last="Sun">Xiao-Wen Sun</name></author><author><name sortKey="Xia, Shu Jie" sort="Xia, Shu Jie" uniqKey="Xia S" first="Shu-Jie" last="Xia">Shu-Jie Xia</name></author></analytic><series><title level="j">Lasers in medical science</title><idno type="eISSN">1435-604X</idno><imprint><date when="2014" type="published">2014</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Acute Disease</term><term>Aged</term><term>Aged, 80 and over</term><term>Humans</term><term>Laser Therapy</term><term>Lasers, Solid-State</term><term>Length of Stay</term><term>Male</term><term>Middle Aged</term><term>Postoperative Period</term><term>Prospective Studies</term><term>Prostatic Hyperplasia (complications)</term><term>Quality of Life</term><term>Treatment Outcome</term><term>Urinary Retention (etiology)</term><term>Urinary Retention (surgery)</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Prostatic Hyperplasia</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Urinary Retention</term></keywords><keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Urinary Retention</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Acute Disease</term><term>Aged</term><term>Aged, 80 and over</term><term>Humans</term><term>Laser Therapy</term><term>Lasers, Solid-State</term><term>Length of Stay</term><term>Male</term><term>Middle Aged</term><term>Postoperative Period</term><term>Prospective Studies</term><term>Quality of Life</term><term>Treatment Outcome</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Two-micrometer thulium laser resection of the prostate-tangerine technique (TmLRP-TT) has been introduced as a minimally invasive treatment for benign prostatic hyperplasia (BPH). Acute urinary retention (AUR) is a common and serious complication of BPH. The study was undertaken to assess the clinical efficacy and safety of TmLRP-TT in the treatment of patients with AUR secondary to BPH. A prospective evaluation of 52 patients undergoing TmLRP-TT from December 2011 to November 2012 was carried out. Preoperative status, surgical details, and perioperative complications were recorded. The follow-up outcome was evaluated with subjective and objective tests at 1 and 6 months. Mean age was 70.3 ± 7.8 years old. Mean prostate volume was 69.6 ± 31.6 ml, and mean residual volume with retention was 274.5 ± 150.7 ml. Mean operative time was 64.1 ± 30.4 min. Mean catheterization duration was 5.4 ± 1.1 days. The mean International Prostate Symptom Score, quality of life score, and postvoid residual urine volume decreased significantly at 6-month follow-up (21.6 ± 6.8 vs. 6.8 ± 3.2, 4.4 ± 1.2 vs. 0.9 ± 0.8, 274.5 ± 150.7 vs. 40.6 ± 22.5 ml). The mean maximum urinary flow rate was 18.7 ± 6.9 ml/s postoperative. Two (3.8 %) of the patients required blood transfusion in operation. Five (9.6 %) of the patients had transient hematuria postoperative, and two (3.8 %) of them received 3 days recatheterization due to clot retention. The early clinical results suggest that the TmLRP-TT is a promising safe, effective, and minimally invasive treatment for patients with AUR secondary to BPH. The incidence of complications was low.</div></front></TEI><pubmed><MedlineCitation Owner="NLM" Status="MEDLINE"><PMID Version="1">24189927</PMID><DateCreated><Year>2014</Year><Month>05</Month><Day>23</Day></DateCreated><DateCompleted><Year>2015</Year><Month>12</Month><Day>08</Day></DateCompleted><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1435-604X</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>3</Issue><PubDate><Year>2014</Year><Month>May</Month></PubDate></JournalIssue><Title>Lasers in medical science</Title><ISOAbbreviation>Lasers Med Sci</ISOAbbreviation></Journal><ArticleTitle>Two-micrometer thulium laser resection of the prostate-tangerine technique for patients with acute urinary retention.</ArticleTitle><Pagination><MedlinePgn>1093-8</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10103-013-1474-3</ELocationID><Abstract><AbstractText>Two-micrometer thulium laser resection of the prostate-tangerine technique (TmLRP-TT) has been introduced as a minimally invasive treatment for benign prostatic hyperplasia (BPH). Acute urinary retention (AUR) is a common and serious complication of BPH. The study was undertaken to assess the clinical efficacy and safety of TmLRP-TT in the treatment of patients with AUR secondary to BPH. A prospective evaluation of 52 patients undergoing TmLRP-TT from December 2011 to November 2012 was carried out. Preoperative status, surgical details, and perioperative complications were recorded. The follow-up outcome was evaluated with subjective and objective tests at 1 and 6 months. Mean age was 70.3 ± 7.8 years old. Mean prostate volume was 69.6 ± 31.6 ml, and mean residual volume with retention was 274.5 ± 150.7 ml. Mean operative time was 64.1 ± 30.4 min. Mean catheterization duration was 5.4 ± 1.1 days. The mean International Prostate Symptom Score, quality of life score, and postvoid residual urine volume decreased significantly at 6-month follow-up (21.6 ± 6.8 vs. 6.8 ± 3.2, 4.4 ± 1.2 vs. 0.9 ± 0.8, 274.5 ± 150.7 vs. 40.6 ± 22.5 ml). The mean maximum urinary flow rate was 18.7 ± 6.9 ml/s postoperative. Two (3.8 %) of the patients required blood transfusion in operation. Five (9.6 %) of the patients had transient hematuria postoperative, and two (3.8 %) of them received 3 days recatheterization due to clot retention. The early clinical results suggest that the TmLRP-TT is a promising safe, effective, and minimally invasive treatment for patients with AUR secondary to BPH. The incidence of complications was low.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhuo</LastName><ForeName>Jian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Urology, Shanghai First People's Hospital, School of Medicine, Shanghai Jiao Tong University, No.100, Haining Road, Shanghai, 200080, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Hai-bin</ForeName><Initials>HB</Initials></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Fu-jun</ForeName><Initials>FJ</Initials></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Feng</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Bang-min</ForeName><Initials>BM</Initials></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Xiao-wen</ForeName><Initials>XW</Initials></Author><Author ValidYN="Y"><LastName>Xia</LastName><ForeName>Shu-jie</ForeName><Initials>SJ</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>11</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lasers Med Sci</MedlineTA><NlmUniqueID>8611515</NlmUniqueID><ISSNLinking>0268-8921</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName MajorTopicYN="N" UI="D000208">Acute Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D000369">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="Y" UI="D053685">Laser Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="Y" UI="D053844">Lasers, Solid-State</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D007902">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D011184">Postoperative Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D011446">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D011470">Prostatic Hyperplasia</DescriptorName><QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D011788">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D016055">Urinary Retention</DescriptorName><QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName><QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>9</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2013</Year><Month>10</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="aheadofprint"><Year>2013</Year><Month>11</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>11</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>11</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="doi">10.1007/s10103-013-1474-3</ArticleId><ArticleId IdType="pubmed">24189927</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Terre/explor/ThuliumV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000231 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000231 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Terre
|area= ThuliumV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:24189927
|texte= Two-micrometer thulium laser resection of the prostate-tangerine technique for patients with acute urinary retention.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:24189927" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a ThuliumV1
| This area was generated with Dilib version V0.6.21. |  |